Bayer To Buy Teva Animal Health For $145 Million

Bayer HealthCare LLC is readying to spend up to $145 million to acquire Teva Pharmaceutical Industries Ltd.

Bayer HealthCare LLC of Shawnee, Kan., plans to acquire the animal health business of Teva Pharmaceutical Industries Ltd. of Jerusalem, for up to $145 million, the companies reported Thursday.

The companies signed an agreement through which Bayer will acquire Teva’s animal health business for an upfront payment of $60 million plus $85 million in milestone payments linked to manufacturing and sales targets.

Bayer will acquire Teva’s portfolio of animal health products, including the DVM Pharmaceuticals brand of veterinary dermatology products, a line of companion animal nutraceuticals and several food animal products, including anti-infectives, parasiticides, anti-inflammatories and reproductive hormones. Bayer will also obtain Teva’s manufacturing site in St. Joseph, Mo., which employees about 300 people.

“Bayer’s acquisition of Teva Animal Health will further strengthen and broaden our U.S. range of animal care solutions so that, together with our customers, we can continue to protect, cure and care for animals across America,” said Ian Spinks, president and general manager of Bayer Healthcare Animal Health North America. “The businesses are a great strategic fit, and Teva’s animal health portfolio adds new depth for us across both the companion and food animal areas.”

The companies expect to close the deal in 2013, subject to antitrust clearance and satisfaction of other conditions, they reported.

<HOME>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.